- Home
- DVAX
DVAX
Dynavax Technologies Corporation
as 03-31-2025 9:35am EST
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | N/A | IPO Year: | 2004 |
| Target Price: | $25.33 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.74 - $14.63 | Next Earning Date: | 05-07-2025 |
| Revenue: | $277,246,000 | Revenue Growth: | 19.36% |
| Revenue Growth (this year): | 20.07% | Revenue Growth (next year): | 18.34% |
Stock Insider Trading Activity of Dynavax Technologies Corporation (DVAX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Novack David F | DVAX | President & COO | Mar 18 '25 | Sell | $13.58 | 14,020 | $190,391.60 | 8,078 | |
| Novack David F | DVAX | President & COO | Mar 7 '25 | Sell | $14.39 | 32,764 | $471,473.96 | 8,078 |
Latest Dynavax Technologies Corporation News
DVAX Breaking Stock News: Dive into DVAX Ticker-Specific Updates for Smart Investing
Yahoo Finance
19 minutes ago
Moderna, biotech stocks slide following resignation of FDA official Peter Marks
Argus Research
6 days ago
DVAX: What does Argus have to say about DVAX?
Zacks
11 days ago
Why Dynavax Technologies (DVAX) Stock Might be a Great Pick
Zacks
19 days ago
Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
MT Newswires
21 days ago
Dynavax Activist Investor Deep Track Capital Sends Letter to Company Board, Urging Director, Strategy Changes
Business Wire
21 days ago
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
MT Newswires
25 days ago
Dynavax Signs Debt Refinancing Deals, Plans $8 Million Stock Buyback
PR Newswire
25 days ago
Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
Compare DVAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DVAX Dynavax Technologies Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.